Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day −1 ) in the treatment of cutaneous or lymphocutaneous sporotrichosis

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day −1 ) in the treatment of cutaneous or lymphocutaneous sporotrichosis

Chapman, S. W.; Pappas, P.; Kauffmann, C.; Smith, E. B.; Dietze, R.; Tiraboschi-Foss, N.; Restrepo, A.; Bustamante, A. B.; Opper, C.; Emady-Azar, S.; Bakshi, R.

2004-02

Citation: Chapman, S. W.; Pappas, P.; Kauffmann, C.; Smith, E. B.; Dietze, R.; Tiraboschi-Foss, N.; Restrepo, A.; Bustamante, A. B.; Opper, C.; Emady-Azar, S.; Bakshi, R. (2004). "Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day −1 ) in the treatment of cutaneous or lymphocutaneous sporotrichosis." Mycoses 47(1-2): 62-68. <http://hdl.handle.net/2027.42/74074>

ISSN: 0933-7407, 1439-0507

DOIs: 10.1046/j.1439-0507.2003.00953.x

PMID: 14998402

URI: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14998402&dopt=citation

Handle: http://hdl.handle.net/2027.42/74074

Show full item record